Results 161 to 170 of about 14,298 (222)

A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling. [PDF]

Cell Rep Med
Rodriguez C, Edinger RS, Diehl G, Reyes-González JM, Lee W, Buckley J, Oh J, Nambiar D, Baidoo K, Okada R, Phadke I, Schmiechen Z, Khan H, Sakhalkar Y, Cortez AG, Josefsson A, Nedrow JR, White A, Citrin DE, Zhang X, Anderson CJ, Escorcia FE, Patel RB, Nguyen R.   +23 more
europepmc   +1 more source

Cryogenic magnetocaloric effect in a disordered double-perovskite Gd₂MnZnO₆. [PDF]

RSC Adv
Petrov DN, Ćwik J, Koshkid'ko YS, Babij M, Ho TA, Phan TL, Khan DT, Dang NT, My KTH, Kim DH.   +9 more
europepmc   +1 more source

The Role of Precision Medicine in Neuroblastoma: Targeted Therapies and Personalized Approaches-A Narrative Review. [PDF]

Health Sci Rep
Mawa MJ, Biswas MS, Haque M, Podder MK.
europepmc   +1 more source

Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody. [PDF]

J Immunother Cancer
Luo W, Zhang HF, Li W, Xu C, Zhu H, Pereira M, Lyberger J, Eguchi S, Liao Y, Rosenblum JM, Marcondes M, Behbehani G, Sorensen PH, Lee D, Cairo MS.   +14 more
europepmc   +1 more source

Targeted Therapies in Neuroblastoma: A History and a View to the Future. [PDF]

Cancers (Basel)
Shah N.
europepmc   +1 more source

Immunotherapy for pediatric solid tumors: overcoming biological barriers through rational multimodal combinations. [PDF]

Cancer Immunol Immunother
Fatahichegeni M, Ansarian MA, Xiao M, Gao W, Shi R.   +4 more
europepmc   +1 more source

HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicity. [PDF]

Front Immunol
Tebaldi G, Egan KP, Hook LM, Cairns TM, Bergstrom T, Campbell KS, Cohen GH, Friedman HM.   +7 more
europepmc   +1 more source

CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. [PDF]

Cancer Metastasis Rev
Wells J, Gupta A.
europepmc   +1 more source

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma. [PDF]

Bone Marrow Transplant
Castelli S, Flaadt T, Schulze F, Thole-Kliesch TM, Zirngibl F, Oevermann L, Künkele A, Astrahantseff K, Schulte S, Duell L, Fuchs J, Simon T, Hero B, Hundsdoerfer P, Rogasch JMM, Lang P, Warmann S, von Stackelberg A, Schulte JH, Eggert A, Deubzer HE.   +20 more
europepmc   +1 more source

End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta. [PDF]

Cancers (Basel)
Lu ER, Hoo CPL, Cheung HM, Wong IWC, Fung KFK, Chang SLY, Lee ACW, Fu ECH, Ku DTL, Yau JPW, Shing MMK, Mak CYK, Liu APY, Chan GCF.   +13 more
europepmc   +1 more source